QualityStocksNewsBreaks – Zenosense, Inc. (ZENO) Continues to Reach Key Milestones
Zenosense (OTC: ZENO) is an innovative healthcare technology developer engaged in transformational, disruptive medical diagnostic projects. Recently, the company has achieved two major milestones. An article discussing the company’s recent success reads: “Health care technology company Zenosense, Inc. (OTCQB: ZENO) has completed two important milestones recently. The first was a successful second round of quantitative testing for the MIDS detection technology; the technology is core to the development of MIDS Cardiac™, a handheld device to rapidly test for certain cardiac biomarkers at the point of care. The second milestone relates to the company’s uplisting to the OTC Markets Group OTCQB…